Navigation Links
Cardium Announces Appointment of Paul A. Foster, M.D. to Lead Generx and Excellarate Late-Stage Development Activities
Date:7/28/2008

SAN DIEGO, July 28 /PRNewswire-FirstCall/ -- Cardium Therapeutics (Amex: CXM) announced the appointment of Paul A. Foster, M.D. as Chief Medical Officer to lead the Company's late-stage clinical development activities at Cardium's Tissue Repair Company for the MATRIX Phase 2b clinical study that is evaluating its Excellarate product candidate for the treatment of diabetic ulcers, and the AWARE Phase 3 clinical study that is evaluating its Generx product candidate as a potential treatment for recurrent myocardial ischemia. Dr. Foster, who is currently Cardium's Vice President and Medical Officer, will assume study oversight responsibilities for both Cardium's and the Tissue Repair Company's clinical programs. Dr. Robert Engler, the Company's Chief Medical Advisor who has been involved in the Generx trials since their inception, will continue to play an active role in those studies, and Dr. Randall Moreadith will continue to focus on evaluating potential new business development and medical device opportunities for the Company.

(Logo: http://www.newscom.com/cgi-bin/prnh/20051018/CARDIUMLOGO)

"We are very pleased to have Paul head up development of our key product candidates as they move through late-stage clinical trials," stated Christopher J. Reinhard, Chief Executive Officer and Chairman of Cardium Therapeutics. "Paul's leadership and extensive clinical experience will greatly assist us as we advance our Generx candidate now in Phase 3, and Tissue Repair's Excellarate candidate, which is expected to complete its key Phase 2 study this year."

Dr. Foster was previously Chief Medical Officer and Vice President of Clinical Development and
'/>"/>

SOURCE Cardium Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Cardium and Tissue Repair Companys Excellarate Candidate for Healing Diabetic Wounds Gains Media Focus in Multiple Regions Across U.S.
2. Cardiums Innercool Therapies Unit Announces Publication of Positive Effects of Early and Rapid Hypothermia Following Heart Attack
3. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
4. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
5. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
6. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
7. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
8. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
9. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
10. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
11. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... JOLLA, Calif. , June 1, 2015 /PRNewswire/ ... ), a biopharmaceutical company leading the discovery and ... that Kleanthis G. Xanthopoulos , Ph.D. has ... as a member of Regulus, Board of Directors, ... biotechnology industry.  Paul Grint, M.D., who previously served ...
(Date:6/1/2015)... DURHAM, N.C. , June 1, 2015  bioMérieux, ... vitro diagnostics, has been invited to join the ... of antibiotic use in the U.S. as a means ... various sectors, will gather tomorrow, June 2, 2015, to ... next five years to slow the emergence of antibiotic-resistant ...
(Date:6/1/2015)... June 1, 2015 Select Medical Holdings Corporation ... Corporation, a joint venture that Select Medical Corporation ("Select") ... completed its previously announced acquisition of Concentra Inc.  Cressey ... venture. About Select Medical Corporation ... hospitals and outpatient rehabilitation clinics in the ...
Breaking Medicine Technology:Regulus' Kleanthis G. Xanthopoulos, Ph.D., to Step Down as President and Chief Executive Officer 2Regulus' Kleanthis G. Xanthopoulos, Ph.D., to Step Down as President and Chief Executive Officer 3Regulus' Kleanthis G. Xanthopoulos, Ph.D., to Step Down as President and Chief Executive Officer 4bioMerieux Honored to Participate in the White House Forum on Antibiotic Stewardship 2bioMerieux Honored to Participate in the White House Forum on Antibiotic Stewardship 3Select Medical Holdings Corporation Announces Completion of Acquisition of Concentra Inc. through Joint Venture with Welsh Carson 2Select Medical Holdings Corporation Announces Completion of Acquisition of Concentra Inc. through Joint Venture with Welsh Carson 3
... Dec. 22, 2011 /PRNewswire-Asia-FirstCall/ -- Golden Meditech Holdings ... 910801.TW), China,s leading integrated healthcare enterprise, today announced that ... market, accumulating a total of 36,976,000 shares in December ... shares at a weighted average price of HK$0.83 per ...
... question confronting neuroscientists and computer vision researchers alike is how ...  Introspectively, we know that the human brain solves this problem ... know what it is. But teaching a computer ... research published this fall in the Public Library of ...
Cached Medicine Technology:Golden Meditech Further Repurchases Shares 2Do You See What I See: Scientists Model Brain Structure To Help Computers Recognize Objects 2Do You See What I See: Scientists Model Brain Structure To Help Computers Recognize Objects 3Do You See What I See: Scientists Model Brain Structure To Help Computers Recognize Objects 4
(Date:6/2/2015)... Cincinnati, OH (PRWEB) June 02, 2015 ... healthcare ministry serving Ohio and Kentucky – has devoted ... Be Well videos to skin cancer prevention. One in ... concise video on Mercy Health’s YouTube channel, a Mercy ...     What are the main causes of skin cancer? ...
(Date:6/2/2015)... 02, 2015 First Choice Emergency ... rooms in the United States, named Kenneth Alan Totz, ... Jones Road facility. , “We are pleased to ... Road facility,” said Dr. James M. Muzzarelli, Executive Medical ... Totz received his undergraduate degree from St. Edwards University ...
(Date:6/2/2015)... Colleen’s Dream Foundation , with fundraising help from ... to support ovarian cancer research conducted by Cheng Wang, Ph.D. ... Colleen’s Dream Foundation Board of Directors. , Cundiff says the ... Colleen’s Dream Foundation and they couldn’t have picked a better ... a rising star in the ovarian cancer world,” says Cundiff. ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 While the ... adaptions of comic books, comic books themselves are stepping ... Comics Uniting Nations plans to produce educational comics in ... Global Goals for Sustainable Development - an international effort ... poverty, hunger, health, education, sustainable energy, inequality, climate change ...
(Date:6/2/2015)... Barbara, CA (PRWEB) June 02, 2015 ... a scholarship fund set up by current and former ... Odajnyk, a beloved faculty member from 2002 until his ... integrity, keen intelligence, and depth of feeling, as well ... and fairytales. His capacities as an analyst, teacher, and ...
Breaking Medicine News(10 mins):Health News:Video provides helpful information about skin cancer prevention 2Health News:First Choice Emergency Room Announces Dr. Kenneth Alan Totz as New Medical Director of Houston – Jones Road Facility 2Health News:Colleen’s Dream Foundation Grants $70,000 to the University of Nebraska Medical Center (UNMC) to Support Ovarian Cancer Research 2Health News:Colleen’s Dream Foundation Grants $70,000 to the University of Nebraska Medical Center (UNMC) to Support Ovarian Cancer Research 3Health News:Can Comics Help the United Nations Save the World? 2Health News:Can Comics Help the United Nations Save the World? 3Health News:Pacifica Graduate Institute - Mythological Studies Students Establish Memorial Scholarship to Honor Dr. V. Walter Odajnyk 2Health News:Pacifica Graduate Institute - Mythological Studies Students Establish Memorial Scholarship to Honor Dr. V. Walter Odajnyk 3
... to researchers from Wake Forest University School of ... restlessness associated with dementia are found to increase ... over-burdened or depressed. ,‘These symptoms are part ... them, but certain styles of caregiving may bring ...
... treatment methods for asthma attacks are found to be ... shows//. Spacer plays shorter stays in emergency departments usually ... Christopher Cates, M.D., of the University of Alberta, in ... children ages 2 years and older, and 614 adults ...
... resident doctors of Indira Gandhi Medical College, Shimla and ... light procession in protest against reservation to other backward ... and doctors also organized a blood donation camp in ... parallel OPDs. The medicos vowed to continue their struggle ...
... Prime Minister Manmohan Singh's appeal, the stalemate between government ... doctors persisted with their hunger strike for the tenth ... quo and we will continue our strike as government ... experts to review the reservation policy,' Dr Vinod Patro, ...
... brain tissue is possible in individuals exposed to lead after 18 ... of the American Academy of Neurology, May 23 2006. ,The ... had not been exposed to lead for an average of 18 ... of more than eight years. ,The researchers measured the ...
... eyesight to juvenile diabetes, has managed to urge scientists and ... her and thousands like herself to see despite failing visual ... was examined with a scanning laser ophthalmoscope, when she was ... a few years. "For a poet, that's an incredible feeling," ...
Cached Medicine News:Health News:Symptoms In Dementia Patients Negatively Correlates With The Characteristics Of Caregivers 2Health News:Spacers Score Over Nebulizers in Childhood Asthma Treatment 2Health News:Loss and damage to the brain cells possible with lead exposure in years ahead 2
... into the punctal opening to block tear ... long-term relief of dry eye symptoms, and ... its own natural tears:, Low-profile cap ... of cap design facilitates easy removal with ...
Extended Duration absorbable plugs are designed to provide patient comfort for up to 3 months. This long lasting plug is effective and economical for transient dry eye symptoms following surgery. Ext...
Attain Left-heart Lead Delivery Systems. Medtronic offers left-heart lead delivery systems to assist with accessing the coronary sinus (cs)....
Attain™ Left-heart Lead Options to Fit Your Patient's Anatomy. Navigate moderately to greatly angled veins with high tortuosity....
Medicine Products: